Medivolve Inc MEDVF

Healthcare Copper

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.

OTCPK:MEDVF - Post by User

Medivolve Inc

<< Previous

Bullboard Posts

Next >>

Post by Sarb99on Dec 13, 2020 2:06pm

247 Views

Post# 32095976

QSC stock prices have a lot of room to grow.

If you look at this slide closely, it shows projected weekly performance. Collection sites should be performing 17325 tests this week, and by the middle of January, collection sites projection is about 126,000 tests per week. If we do the calculation revenue as of now with 17325 tests x$95 =$1,645,875 per week. By January 17th with 126000x$95=$11,970,000 per week. It worked out about a $10 million revenue increase per week.

So, I think with the weekly increase, QSC stock price should keep going up steadily. Once we start converting this revenue to Canadian Dollars $11,970,000x1.30=$15,561,000, weekly revenue is a lot of money for a company with a market cap of less than $45 million.

User image